Clinical Trial Update: BMS-247550 in Treating Patients With Advanced Cancers [Phase 1]

View source ↗

Summary

Phase 1 trial update of BMS-247550 in patients with advanced cancers, including lymphoma and small intestine cancer; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Small Intestine Cancer

Drugs mentioned

• BMS-247550

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Lymphoma, Small Intestine Cancer | Phase 1 | Status: COMPLETED